The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
The new assay consolidates screening for four major viral threats into a single workflow
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
Subscribe To Our Newsletter & Stay Updated
